Inventor · disambiguated record
Hui Huang
Also filed as: HUANG HUI · HUANG HUI-YU
21 granted patents·5 pending applications·88 citations·filing 2002–2024
92Inventor score
Files withJANSSEN PHARMACEUTICA NV13DIMENSIONAL PHARM INC2VERINATA HEALTH INC2BENED BIOMEDICAL CO LTD1BIGNAN GILLES1
Top patents by PatentIndex Score
26 records- 0192US9301983B2Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetesGENMONT BIOTECH INC·Filed 2014·Granted Apr 5, 2016·14 cites·10 claims
- 0287US7138530B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Nov 21, 2006·29 cites·48 claims
- 0386US9845552B2Set membership testers for aligning nucleic acid samplesVERINATA HEALTH INC·Filed 2012·Granted Dec 19, 2017·11 cites·21 claims
- 0483US7109354B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Sep 19, 2006·17 cites·16 claims
- 0582US9193736B2PDE 10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 24, 2015·7 cites·14 claims
- 0680US9920040B2GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Mar 20, 2018·2 cites·32 claims
- 0780US9908873B2GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Mar 6, 2018·2 cites·30 claims
- 0880US9856245B2GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jan 2, 2018·2 cites·31 claims
- 0973US8796256B2Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulatorsBIGNAN GILLES·Filed 2011·Granted Aug 5, 2014·3 cites·28 claims
- 1071US7642270B25-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jan 5, 2010·1 cites·12 claims
- 1166US2025099517A1Use of Lactobacillus reuteri Y7 strain for prevention or treatment of ocular diseasesHuang hui yu·Filed 2024·Application pending·0 cites
- 1265US10662170B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 26, 2020·0 cites·2 claims
- 1362US2024277708A1Use of [1,2,4] Triazolo [4,3-B] Pyridazine Derivative For Preventing and Treating Senescence and Senescence-Related DiseasesTHE EIGHTH AFFILIATED HOSPITAL SUN YAT SEN UNIV·Filed 2023·Application pending·0 cites
- 1458US10131648B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 20, 2018·0 cites·14 claims
- 1554US11335437B2Set membership testers for aligning nucleic acid samplesVERINATA HEALTH INC·Filed 2017·Granted May 17, 2022·0 cites·17 claims
- 1653US9790198B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 17, 2017·0 cites·22 claims
- 1752US2024085429A1Altering protein function by pharmacological targeting of membrane domainsUNIV VIRGINIA PATENT FOUNDATION·Filed 2022·Application pending·0 cites
- 1851US10988433B2Cyclohexyl GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 27, 2021·0 cites·44 claims
- 1949US11938156B2Lactic acid bacteria and its applicationsBENED BIOMEDICAL CO LTD·Filed 2019·Granted Mar 26, 2024·0 cites·5 claims
- 2048US9249163B2PDE10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 2, 2016·0 cites·19 claims
- 2148US2003211504A1Methods for identifying nucleic acid polymorphismsFiled 2002·Application pending·0 cites
- 2244US7550474B2Substituted phenyl acetamides and their use as protease inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jun 23, 2009·0 cites·42 claims
- 2341US7728003B25-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 1, 2010·0 cites·8 claims
- 2441US2008114007A15-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinasePLAYER MARK R·Filed 2007·Application pending·0 cites
- 2540US10106553B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 23, 2018·0 cites·19 claims
- 2636US9688642B2Substituted pyrazines as GPR40 agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 27, 2017·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Hui Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →